zpět na hlavní stránku    kontakt
in english
English  
Česká společnost klinické farmakologie     Česká lékařská společnost J.E.P.


Prof. Pierre Marquet, MD, PhD
back to list

Pierre Marquet conducts translational research on the immunosuppressive drugs (IS) in organ transplantation, including: metabolic, pharmacogenetic and pharmacodynamic studies of the IS; investigation of early biomarkers of graft injuries; mechanisms of IS nephrotoxicity; epidemiological studies and clinical trials in transplant patients; and application to routine treatment personalization in transplant recipients.
He has published over 160 papers in peer-reviewed, international journals.
He was presented with the Young Scientist Award of the French Society of Analytical Toxicology (1995), the IATDMCT Young Investigator Award (2001) and Pippenger Award for outstanding contributions to Therapeutic Drug Monitoring (2009).

Pierre Marquet is currently:
Past-president of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) (2013-2015)
Director of the INSERM U850 research unit called "Pharmacology of immunosuppressive drugs in transplantation" (INSERM is the French Institute of Medical and Health Research)
Head of the "Pharmacology, Toxicology and Pharmacovigilance" Department at the University Hospital of Limoges
Vice-President of the board of Directors of University Hospital of Limoges, in charge of research
Member of the Administrative Council and founding President of the Scientific Council of the French Society of Pharmacology and Therapeutics (SFPT)
Coordinator of the "drugs and pharmacology" working group of the French-speaking Society of Transplantation (SFT)

Pierre Marquet conducts translational research on the immunosuppressive drugs (IS) in organ transplantation, including: metabolic, pharmacogenetic and pharmacodynamic studies of the IS; investigation of early biomarkers of graft injuries; mechanisms of IS nephrotoxicity; epidemiological studies and clinical trials in transplant patients; and application to routine treatment personalization in transplant recipients.
He has published over 160 papers in peer-reviewed, international journals.
He was presented with the Young Scientist Award of the French Society of Analytical Toxicology (1995), the IATDMCT Young Investigator Award (2001) and Pippenger Award for outstanding contributions to Therapeutic Drug Monitoring (2009).
 
© 2013 ČSKF     Valid HTML 4.01 Transitional